Randomized,controlled,open study to evaluate the response to r-TPA therapy vs clinical standard therapy in patients affected by ictus at awakening coming in ER within 3 hours from symptoms compare.

Trial Profile

Randomized,controlled,open study to evaluate the response to r-TPA therapy vs clinical standard therapy in patients affected by ictus at awakening coming in ER within 3 hours from symptoms compare.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 May 2012

At a glance

  • Drugs Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms WUS-rTPA
  • Most Recent Events

    • 23 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top